HCPCS Level IIdrugActive
J1939
Inj, bumetanide, 0.5 mg
BETOS: O1E
Effective: 2025-01-01
Description
Injection, bumetanide, 0.5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Bumetanide
Manufacturer
Hikma Pharmaceuticals USA Inc.
HCPCS Dosage
0.5 MG
Billing Units
5.0000
21
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.